Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,600 | -3,507 | -2,193 | -1,279 | -5,931 |
| Other Working Capital | -801 | -649 | -898 | -750 | 1,046 |
| Other Operating Activity | 2,049 | 1,764 | 1,457 | 1,130 | 900 |
| Operating Cash Flow | $-3,352 | $-2,392 | $-1,633 | $-899 | $-3,985 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,044 | 3,315 | 1,124 | 0 | 4,455 |
| Financing Cash Flow | $4,044 | $3,315 | $1,124 | $N/A | $4,455 |
| Beginning Cash Position | 2,483 | 2,483 | 2,483 | 2,483 | 2,013 |
| End Cash Position | 3,175 | 3,407 | 1,974 | 1,584 | 2,483 |
| Net Cash Flow | $692 | $923 | $-509 | $-899 | $470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,352 | -2,392 | -1,633 | -899 | -3,985 |
| Free Cash Flow | -3,352 | -2,392 | -1,633 | -899 | -3,985 |